NYSE: BMY - Bristol-Myers
Rentabilité sur six mois: -9%
Rendement en dividendes: +4.61%
Secteur: Healthcare
Nouvelles
18 novembre 17:57 Western drugmakers are still providing medicines to Russia
18 novembre 17:51 Drugmakers raised prices by 6.6% on average early this year
18 novembre 17:46 Stock futures trade mixed ahead of Fed decision
18 novembre 17:35 Bristol Myers to buy RayzeBio for about $4.1B
18 novembre 17:20 Warren Buffett's Berkshire Hathaway shakes up investment holdings
18 novembre 16:56 Bristol Myers to buy Karuna Therapeutics for $14B
